Other key findings:

Drug prices aren't the only threat to affordability. Lack of transparency (73%), hospital prices (71%), surprise medical bills (58%) and overuse of low-value services/waste (53%) were cited as significant threats.
Employers are receptive to implementing national or regional centers of excellence. With few exceptions, employers with more than 5,000 covered workers either already use COEs or are considering it over the next two years, and over three-quarters of mid-sized employers currently use COEs or are thinking about it. Even the smallest employers are open to the idea, as only about a third outright rejecting it.
In addition to drug price regulation, employers agreed hospital price transparency (90%), surprise billing regulation (81%) and hospital rate regulation (79%) would be at least somewhat helpful in addressing affordability. Medicare for All was widely rejected with 46% saying it would be harmful, and 22% neutral on the idea.

Read more:

Self-insured employers may be leaving money on the table by not regularly evaluating pharmacy benefits
COVID sparks increased concern about drug prices
How to improve transparency and take control over health care costs

Instant Insights /

Employers' attitudes toward health care reform changing